Semnur Pharmaceuticals, Inc.
SMNR
$0.84
$0.045.01%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,371.43% | 66.67% | -- | 266.67% | -41.67% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 28,700.00% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -82.14% | -90.06% | -- | 32,169.23% | -- |
|
|
|||||
| Total Current Assets | -82.14% | -90.06% | -- | 32,169.23% | -- |
| Net Property, Plant & Equipment | 8.85% | 8.85% | -- | 0.00% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -73.79% | -79.86% | -- | 1,169.79% | -- |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 546.74% | 2,011.43% | -- | 1,888.06% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 0.00% | -- |
| Total Other Current Liabilities | -- | -- | -- | 0.00% | -- |
| Total Current Liabilities | 4,914.49% | 28,951.43% | -- | 1,405.56% | -- |
|
|
|||||
| Total Current Liabilities | 4,914.49% | 28,951.43% | -- | 1,405.56% | -- |
| Long-Term Debt | -66.67% | -75.87% | -- | 26.22% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -46.44% | -55.33% | -- | 29.21% | -- |
|
|
|||||
| Common Stock & APIC | 251.31% | 251.31% | -- | 0.00% | -- |
| Retained Earnings | -141.60% | -139.03% | -- | -3.30% | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 41.71% | 51.50% | -- | -9.18% | -14.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 41.71% | 51.50% | -- | -9.18% | -14.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 41.71% | 51.50% | -- | -9.18% | -14.06% |
|
|
|||||